Hodgkin lymphoma
Disease1 paper
- Humans1
Trial sponsors
Company2 trialsPhase 41,458 people
Company1 trialPhase 2340 people
Company1 trialPhase 2255 people
Company1 trialPhase 257 people
Company1 trialPhase 1/2320 people
Company1 trialPhase 1/2119 people
7 trialsPhase 32,523 people
2 trialsPhase 3489 people
Latest
3Blood AdvancesHumans
Electronic frailty index predicts CAR-T outcomes in older adults
Very frail older patients had worse overall survival (HR=1.64) and event-free survival (HR=2.02) after CAR-T therapy than robust or prefrail peers.Very frail older patients had worse overall survival (HR=1.64) and event-free survival (HR=2.02) after CAR-T therapy than robust or prefrail peers.